Resources

Your selections:

Clear all

Show Filters

We found 263 resources that match your search.

No new or unexpected side effects are observed with the FTC 200 mg/TDF 300 mg combination tablet than those observed when each drug is given separately.

Document Date:

TRUVADA is a combination of EMTRIVA and VIREAD, both nucleoside analog HIV-1 reverse transcriptase inhibitors.TRUVADA is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 17 kg. TRUVADA is indicated in…

Document Date:

Document Date:

Document Date:

Document Date:

Document Date:

Document Date:

Document Date:

Vepesid is used in the treatment of certain types of cancer, in particular small cell lung cancer and testicular cancer.


INTELENCE® is a human immunodeficiency virus type 1 (HIV-1) non-nucleoside reverse transcriptase inhibitor(NNRTI) indicated for treatment of HIV-1 infection in treatment-experienced patients 6 years of age and older with viral strains resistant to an NNRTI and other antiretroviral agents.

Document Date:

Purpose: To define general informed consent procedures. Scope: This procedure applies to all staff involved in obtaining informed consent. (Adapted from the Microbicide Trials Network)

Document Date:

Purpose: To define informed assent/permission/consent procedures for potential participants who are children. Scope: This procedure applies to all staff involved in obtaining informed assent, parental permission, and consent when children are research participants.  (Adapted from the…

Document Date:

Clinical investigators disclosure of financial interests and arrangements.

Document Date:

Clinical investigators disclosure of financial interests and arrangements.

Document Date:

HVTN IND study financial disclosure form.

Document Date:

Disclosure of financial Interests and arrangements form for IMPAACT Clinical Investigators.

Document Date:

MTN financial disclosure/certification form.

Document Date:

Non-network financial disclosure/certification form.

Document Date: